Liquid Biopsies in NSCLC May Prolong Patients ' Lives Liquid Biopsies in NSCLC May Prolong Patients ' Lives

Patients with ctDNA alterations who received targeted therapy on the basis of these alterations survived longer than patients who did not receive targeted therapy.
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news